NCT04483011View on ClinicalTrials.gov

The Safety and Efficacy Study of RiaGev in Healthy Adults

NAUnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

July 30, 2020

Study Completion Date

November 30, 2020

Conditions
Metabolic SyndromePremature Aging
Interventions
DIETARY_SUPPLEMENT

RiaGev

Dietary supplementation

Trial Locations (1)

55114

Prism Research, Inc., Saint Paul

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

collaborator

University of Washington

OTHER

lead

Bioenergy Life Science, Inc.

INDUSTRY

NCT04483011 - The Safety and Efficacy Study of RiaGev in Healthy Adults | Biotech Hunter | Biotech Hunter